Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 2.3B | 2.5B | 2.7B | 2.8B |
Cost of revenue | 1.6B | 1.7B | 1.9B | 1.9B |
Gross profit | 705M | 728M | 819M | 867M |
Operating expense | ||||
Research & development | 26M | 23M | 25M | 26M |
Selling general and admin | 374M | 378M | 421M | 425M |
Other operating expenses | — | — | — | — |
Operating income | 295M | 308M | 354M | 396M |
Non operating interest income | ||||
Income | 0 | 5M | 8M | 4M |
Expense | 85M | 85M | 88M | 87M |
Other income expense | -26M | -147M | -27M | -29M |
Pretax income | 184M | 81M | 247M | 284M |
Tax provision | 39M | 15M | 74M | 66M |
Net income | 145M | 66M | 173M | 218M |
Basic EPS | 0.5 | 0.2 | 0.6 | 0.7 |
Diluted EPS | 0.5 | 0.2 | 0.6 | 0.7 |
Basic average shares | 298M | 298M | 298M | 298M |
Diluted average shares | 299M | 299M | 299M | 301M |
EBITDA | 382M | 431M | 476M | 511M |
Net income from continuing op. | 145M | 66M | 173M | 218M |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | — | — | — | — |